Page last updated: 2024-09-03

gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and Cardiac Failure

gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate has been researched along with Cardiac Failure in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bakos, Z; Borgquist, R; Carlsson, M; Markstad, H; Ostenfeld, E; Roijer, A1

Other Studies

1 other study(ies) available for gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and Cardiac Failure

ArticleYear
Combined preoperative information using a bullseye plot from speckle tracking echocardiography, cardiac CT scan, and MRI scan: targeted left ventricular lead implantation in patients receiving cardiac resynchronization therapy.
    European heart journal. Cardiovascular Imaging, 2014, Volume: 15, Issue:5

    Topics: Aged; Cardiac Resynchronization Therapy; Contrast Media; Echocardiography; Feasibility Studies; Female; Heart Failure; Heart Ventricles; Heterocyclic Compounds; Humans; Image Interpretation, Computer-Assisted; Iohexol; Magnetic Resonance Imaging; Male; Organometallic Compounds; Tomography, X-Ray Computed

2014